SMTL ID : 1hvr.1

RATIONAL DESIGN OF POTENT, BIOAVAILABLE, NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

homo-dimer

Ligands

1 x XK2: [4R-(4ALPHA,5ALPHA,6BETA,7BETA)]-HEXAHYDRO-5,6-DIHYDROXY-1,3-BIS[2-NAPHTHYL-METHYL]-4,7-BIS(PHENYLMETHYL)-2H-1,3-DIAZEPIN-2-ONE(Non-covalent)

XK2.1: 26 residues within 4Å: Chain A: R.8, D.25, G.27, A.28, D.29, D.30, V.32, I.47, G.48, G.49, I.50, P.81, V.82, I.84 Chain B: R.8, D.25, G.27, A.28, D.29, D.30, V.32, I.47, G.48, G.49, I.50, P.81 18 PLIP interactions: 8 interactions with chain B, 10 interactions with chain A Hydrophobic interactions: B:A.28, B:D.30, B:V.32, B:I.47, B:I.50, B:P.81, A:A.28, A:D.30, A:V.32, A:I.47, A:I.50, A:P.81, A:V.82, A:I.84 Hydrogen bonds: B:G.27, B:I.50, A:D.25, A:I.50

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lam, P.Y. et al., Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. Science (1994)

Release Date

1995-01-26

Peptides

HIV-1 PROTEASE: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

HIV-1 PROTEASE

Related Entries With Identical Sequence